A healthcare royalty company that derives the majority of its revenue from partnered respiratory therapies originally developed with GlaxoSmithKline, including Trelegy Ellipta, Breo Ellipta, and Anoro Ellipta. The firm collects long-term royalties on global sales of these medicines and deploys the c...
1 member of Congress has disclosed 2 trades in Innoviva, Inc. (INVA), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-03-25 | George Whitesides | sell | $250K – $500K |
| 2025-03-24 | George Whitesides | sell | $50K – $100K |